4//SEC Filing
Ahuja Aparna 4
Accession 0000899243-22-001125
CIK 0001492674other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 1:01 PM ET
Size
7.2 KB
Accession
0000899243-22-001125
Insider Transaction Report
Form 4
Ahuja Aparna
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-05+153,664→ 169,599 total - Exercise/Conversion
Restricted Stock Units
2022-01-05−153,664→ 307,328 total→ Common Stock (153,664 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 15,935 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on November 15, 2021.
- [F3]On January 5, 2021 the reporting person was granted 460,992 RSU's that vest in three equal annual installments beginning on January 5, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001840844
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 1:01 PM ET
- Size
- 7.2 KB